Teldar Paper

1.3K posts

Teldar Paper

Teldar Paper

@Paperboy2009

The two most common elements in the universe are hydrogen, and stupidity

NYC 가입일 Mart 2009
1K 팔로잉238 팔로워
Hulk
Hulk@HulkCapital·
Want to try HULK PRO without paying full price? Use code HULKFIRST39 and get your first month for just $39 at HulkCapital.com. 💪
English
1
0
1
840
Teldar Paper
Teldar Paper@Paperboy2009·
@HulkCapitalPro Mkt not pumping like it should with these comments. Ppl not believing his BS as much as before
English
1
0
0
16
Pink Floyd
Pink Floyd@pinkfloyd·
Incredibly, it's now three years since the release of The Dark Side Of The Moon 50th Anniversary editions. What was your favourite aspect of these editions, which were released as separate entities as well as in this box set?
Pink Floyd tweet media
English
14
19
172
7.8K
Teldar Paper
Teldar Paper@Paperboy2009·
@A_May_MD $ABVX is using the threat of a post-data raise as leverage to get a deal beforehand. They have cash into next year. They would need to raise but truly no need to bring it up this early unless they were trying to spur a deal
English
1
0
2
462
Adam May
Adam May@A_May_MD·
$ABVX degen traders dumping the stock on a CNBC article saying exactly what I’ve been saying since the trial hit back in July, and what was already blatantly obvious from the earnings release yesterday. WAITING FOR MAINTENANCE DATA is the ideal negotiating leverage. Read the quote below from the CEO. It could not be more obvious to me that this is the correct strategy. Catalyst wait times don’t get a lot shorter than 3 months in biotech, btw. CHILL. cnbc.com/2026/03/24/abi…
Adam May tweet media
English
27
9
147
11.7K
Teldar Paper
Teldar Paper@Paperboy2009·
@Biomaven Understood, but they have 62MM on the old, and $200 fresh...get busy!
English
0
0
4
57
Peter Suzman
Peter Suzman@Biomaven·
So pretty clear that $TGTX will be dramatically increasing their share repurchases. They just borrowed $500m net (with option for another $250m) at very favorable terms. They are already cash flow positive, and they just increased the amount they can repurchase from $100m to $300m. So far they have only repurchased some $38m at a price under $29. Leveraging up like this absolutely makes sense given they can confidently predict sales and cashflow steadily increasing for several years to come. At some point ever-increasing EPS will drive their stock price higher, and this extra leverage will amplify that process. Companies with an ATM program tend to cap their stock price - any pop and they sell shares. By contrast companies with an active repurchase program provide a floor for the stock price - they will generally buy on any weakness.
English
2
2
20
1.2K
Adam Feuerstein ✡️
Adam Feuerstein ✡️@adamfeuerstein·
Considering this for an updated X profile backdrop. Catchy! Or, do you still prefer Bo on the beach at sunset?
Adam Feuerstein ✡️ tweet media
English
16
0
61
7.9K
Teldar Paper
Teldar Paper@Paperboy2009·
@danprimack Hop-on / hop-off bus tours are a great way to see / get around the city while learning about the history
English
0
0
0
496
Dan Primack
Dan Primack@danprimack·
Taking 15 year-old daughter to Paris next month. Any and all ideas for fun activities (not an art museum kid)...
English
29
1
20
15.1K
Teldar Paper
Teldar Paper@Paperboy2009·
@HulkCapitalPro If you didnt see it, they upped the buyback by anoither $200MM, through financing with Blue Owl
English
0
0
1
53
Logical Thesis
Logical Thesis@LogicalThesis·
Wagyu Tomahawk. Rare+
Logical Thesis tweet mediaLogical Thesis tweet mediaLogical Thesis tweet media
Filipino
13
0
53
6.6K
Teldar Paper
Teldar Paper@Paperboy2009·
@BDC_Analyst I suspect a miracle cure will be coming for all of the $LQDA LT holders afflicted shortly. (disclosure: I've been saying this for months)
English
0
0
12
2K
Blue Duck Cap - Analyst
Blue Duck Cap - Analyst@BDC_Analyst·
$LQDA - Sad to announce that I have been diagnosed with a severe case of LDS. Liquidia Derangement Syndrome. Unfortunately, the doctors have told me it's terminal. If you are a fellow LQDA shareholder, please get a check up asap, you're at an elevated risk if you've been holding it for over a year.
English
6
4
70
5.8K
Teldar Paper
Teldar Paper@Paperboy2009·
@3PeaksTrading I don't know what else they can do to get the mojo back into the stock. They're certainly outperforming, and not being rewarded for it $NVDA
English
1
0
2
141
Teldar Paper
Teldar Paper@Paperboy2009·
@Mr_Derivatives G-d forbid they work on getting rid of the spam / bots. That would certainly be worthy of a tease like that
English
2
0
1
192
Teldar Paper
Teldar Paper@Paperboy2009·
@unemon1 👀 He would certainly know what’s coming down the pike…
English
0
0
2
604
unemon
unemon@unemon1·
$ABVX .... was TOKAT referring to $ABVX when on BBG he said ... "conditions could be ripe for the first 20b+ biopharma deal in more than three years"
unemon tweet media
English
7
1
56
19.3K
Teldar Paper
Teldar Paper@Paperboy2009·
@HulkCapitalPro The will probably raise some cash soon. Current cash through Q1 2027 $CTMX
English
0
0
1
212
Charles Gordon
Charles Gordon@princetongb·
My interpretation from the $ABVX LaLettre is that they have details wrong -> all interested parties have exclusive access to the data room. My guess is that $AZN went for a follow-up visit reserving the calendar date, as may have others on different dates. There is likely a French iBanker staffer responsible for the leaks with a connection to the publication.
English
10
3
65
29K
dough
dough@semodough·
$TGTX not that anyone cares today- but believe anecdotal nuggets out there on Azer-cel is performing very well - heard from last call enrollment exceeding trial sites - now even better details - would be game changer for PPMS which affects 10-15 %of MS patients
dough@semodough

$TGTX nice to hear these 2 updates here Present preliminary Phase 1 azer-cel data in Progressive MS in the second half of 2026 ENROLLMENT is exceeding trial sites 👍 •Announce pivotal topline data for subcutaneous BRIUMVI (ublituximab) year-end SUBq could double peak estimates for $THTX

English
2
4
21
6.2K